Drug Profile
DX 0165
Alternative Names: DX-0165Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator HEC Pharm
- Class Antihyperglycaemics
- Mechanism of Action Dipeptidyl peptidase 4 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Diabetes mellitus
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Diabetes-mellitus in China
- 08 May 2013 Preclinical trials in Diabetes mellitus in China (unspecified route)